---
title: 'Associate Director, Process Development at Replimune'
canonical: 'https://feeny.ai/job/associate-director-process-development-replimune-milton-park-pz1973yzc4jf'
type: 'job'
last_seen: '2026-10-14'
---

# Associate Director, Process Development at Replimune

- **Company:** Replimune
- **Location:** Milton Park
- **Employment:** full-time
- **Work type:** onsite
- **Posted:** 2026-10-07
- **Last confirmed live:** 2026-10-14
- **Apply:** https://jobs.ashbyhq.com/replimune/670514e3-451b-47c9-8382-5b578aafaa3d

## Job description

## Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal. Audacious: We Are Bold. Dedicated: We Give Our Full Commitment. Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

Summary of job description: The Associate Director - Process Development is responsible for managing the Process Development team at Replimune’ s Milton Park facility. The Process Development team at the Milton Park facility collaborates with their PD colleagues in the US to characterize and improve process steps within the cGMP production processes by executing robust bench scale process experiments. The Process Development team at Milton Park is also responsible for the generation of materials to support other departments/studies (assay controls, assay buffers, preclinical / tox material, etc.). The Associate Director will ensure that all work is planned, performed, and reported in an efficient and compliant manner. This position is based in our Milton Park location and typically has a 5-day on-site expectation.

Key responsibilities:

- Leading the Process Development group at Replimune’s Milton Park facility, UK.
- Ensuring lab work is executed as per experimental design instructions (SOP, protocol, batch record, etc.) in a safe and efficient manner.
- Production of suitable material for QC / AD assay controls, preclinical and toxicology studies, etc.
- Author / reviewer of reports, protocols, SOPs, batch records, etc.
- Drive continuous improvement in our cGMP process steps through application of experimental findings.
- Supervises timely creation, completion and archiving records, protocols and technical reports to document the development, characterization and technology transfer pf production processes.
- Ensure effective, high-quality, timely and appropriate documentation in laboratory notebooks. Other responsibilities
- Milton Park PD representative for cross-functional site leadership / administrative meetings.
- Practices and promotes safe work habits and adheres to safety procedures and guidelines
- PD representative for audits of Milton Park facility.
- Provide regular updates of Milton Park PD group activities to senior management.
- Keeps up to date with current technologies and trends in biologics processing
- Some travel may be required, both in country and international.

Educational requirements:

- Bachelor’s degree in applicable field with advanced degree preferred. Experience and skill requirement:
- A minimum of 10 years’ experience (BS) or 6 to 8 years (MS/PhD) in biologics process development or manufacturing
- Thorough understanding of current regulatory requirements and practical experience in support of cGMP operations
- Proven leadership in managing and motivating team members to achieve goals
- Ability to interface effectively with management and other groups or project teams Excellent verbal and written communication skills

## About Replimune

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit [www.replimune.com](http://www.replimune.com). We are an Equal Opportunity Employer.

## About Replimune

## Company Overview
- **One-liner**: Replimune is a clinical-stage biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti-tumor response.
- **Entity Type**: Public (ticker not explicitly provided in search results, but company is publicly traded)
- **Headquarters**: Framingham, Massachusetts, USA (with additional locations in Woburn, MA and Oxfordshire, UK)
- **Founded**: 2015
- **Founders**: Robert Coffin, Ph.D. (Founder and Chief Scientist)

## Core Business
- **Primary industry**: Biotechnology – oncology, oncolytic immunotherapy
- **Target customers**: B2B (pharmaceutical partners) and ultimately patients through healthcare providers
- **Mission**: To ignite a systemic immune response to cancer and reshape the future of cancer care

## Products & Services
- **RPx Platform**: Proprietary, next-generation HSV-1-based oncolytic immunotherapy platform that powers all pipeline candidates.
- **RP1**: Investigational oncolytic immunotherapy for advanced melanoma (IGNYTE trial, PDUFA date April 10, 2026) and non-melanoma skin cancers; also being studied as monotherapy in organ transplant patients with skin cancer (ARTACUS trial).
- **RP2**: Investigational oncolytic immunotherapy for metastatic uveal melanoma (Phase 2/3 RP2-202 trial) and hepatocellular carcinoma (Phase 2 in combination with atezolizumab/bevacizumab).

## Market Standing
- **Valuation/Market Cap**: Not publicly available in provided sources
- **Key Metric**: Clinical-stage; no approved products yet. Key regulatory milestone: FDA action date for RP1 in advanced melanoma on April 10, 2026.
- **Notable Partners**: Bristol-Myers Squibb (supply of nivolumab), Roche (supply of atezolizumab and bevacizumab) – Replimune retains full commercial rights.
- **Growth Signals**: Completed enrollment in IGNYTE trial; confirmatory IGNYTE-3 trial underway; own 63,000 sq ft U.S. manufacturing facility in Woburn, MA enabling global commercial supply; broad pipeline across multiple solid tumor indications.

## Competitive Advantages
- **Strong IP position**: Wholly-owned, unencumbered RPx platform with broad patent protection.
- **In-house manufacturing**: Dedicated U.S. facility for commercial-scale production, reducing reliance on contract manufacturers.
- **First-mover potential**: Poised to be one of the first oncolytic immunotherapies to reach the market if RP1 gains FDA approval.
- **Full rights retained**: All partnership agreements allow Replimune to keep full commercial rights to its therapies.

## Strategic Focus
- Advancing RP1 toward FDA approval in advanced melanoma (April 2026 PDUFA date)
- Expanding pipeline into additional indications (uveal melanoma, hepatocellular carcinoma, non-melanoma skin cancers)
- Building out commercial infrastructure and manufacturing capabilities
- Exploring combination therapies with checkpoint inhibitors (nivolumab, atezolizumab)

## Why Work Here
- **Culture**: Cross-functional, collaborative, values-driven environment. Employee survey results show 92% proud to work at Replimune, 88% feel they make a positive difference, 78% would recommend the company.
- **Flexibility**: Hybrid and remote work options available depending on role; home office and mobile phone stipend provided.
- **Compensation**: New hire equity grants, generous annual bonus plans, retirement plans with substantial company match (100% vested from day one).
- **Benefits**: Medical, dental, and vision insurance 100% paid by the company.
- **Locations**: U.S. (Woburn, MA and Framingham, MA) and UK (Oxfordshire) – opportunities to work across both sites.

## Sources
1. [Replimune Homepage](https://www.replimune.com/)
2. [Replimune Careers](https://www.replimune.com/careers)
3. [Replimune About Us](https://www.replimune.com/about-us)
4. [Replimune Team](https://www.replimune.com/team)
5. [Replimune Pipeline](https://www.replimune.com/pipeline)

## Other roles at Replimune

- [Senior Engineer, Technical Operations](https://feeny.ai/job/senior-engineer-technical-operations-replimune-framingham-hbhptbrvyq18) — Framingham, MA
- [Senior Associate, Clinical Supply Chain](https://feeny.ai/job/senior-associate-clinical-supply-chain-replimune-framingham-0g0qt53fy3ma) — Framingham, MA
- [Director, Data Analytics and Reporting](https://feeny.ai/job/director-data-analytics-and-reporting-replimune-woburn-ex67n99bnkky) — Woburn, MA
- [Validation Engineer II](https://feeny.ai/job/validation-engineer-ii-replimune-framingham-g9ccc3qravmk) — Framingham, MA
- [Associate Director, Facilities and Engineering](https://feeny.ai/job/associate-director-facilities-and-engineering-replimune-milton-park-66qfyefd78es) — Milton Park
- [Senior Quality Control Analyst](https://feeny.ai/job/senior-quality-control-analyst-replimune-milton-park-fem77bn1grad) — Milton Park
- [Quality Control Analyst I](https://feeny.ai/job/quality-control-analyst-i-replimune-milton-park-gsyw4st58cnw) — Milton Park
- [QC Microbiology Technician](https://feeny.ai/job/qc-microbiology-technician-replimune-framingham-nxknzm2vk893) — Framingham, MA
- [Senior Quality Control, Microbiology Analyst](https://feeny.ai/job/senior-quality-control-microbiology-analyst-replimune-framingham-vpvxm0nj5h9a) — Framingham, MA
- [Director, Medical Publications and Scientific Communication](https://feeny.ai/job/director-medical-publications-and-scientific-communication-replimune-woburn-2x89896ezvf6) — Woburn, MA